Back to Invesco Ltd. Invesco Ltd.

ENLVENLV
3 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in ENLIVEX THERAPEUTICS LTD

No. Invesco exited its ENLV (Enlivex Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 61,654 shares worth $57,344. Invesco first reported ENLV in Q4 2025 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$42,839

Total Shares Change

-60,920

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$131.98
0
2026-Q1
Increased
61,654
+1.2%
$57,3440.0%$223.22
14
2025-Q4
New
60,920
-
$42,8390.0%$168.77
31

Other major holders of ENLV: ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used